CRISPR Therapeutics AG (CRSP)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$38.26

Buy

$38.41

arrow-down$-0.345 (-0.92%)

Prices updated at 28 May 2025, 09:29 EDT
| Prices minimum 15 mins delay
|
Prices in USD
CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.
NASDAQ
arrow-down-0.51%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$38.13 - $37.17
$67.88 - $30.04
-
3,214.89m
-
-
1,174
1.76
1,686,086.36
1.83
85.91m
CH0334081137
-4.49
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.